Leukine ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
229	肺胞蛋白症（自己免疫性又は先天性）	3

229. 肺胞蛋白症（自己免疫性又は先天性）

臨床試験数 : 44 / 薬物数 : 22 - (DrugBank : 7) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 14

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01511068 (ClinicalTrials.gov)	August 2012	12/12/2011	Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar P ...	Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar P ...	Hereditary Pulmonary Alveolar Proteinosis	Drug: Leukine	Children's Hospital Medical Center, Cincinnati	Virginia Commonwealth University;Genzyme, a Sanofi Company	Completed	8 Years	N/A	All	2	Phase 2	United States
2	NCT00901511 (ClinicalTrials.gov)	July 2009	11/5/2009	Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimm ...	Whole Lung Lavage Followed by Inhaled Sargramostim in the Treatment of Autoimmune Pulmonary Alveolar ...	Pulmonary Alveolar Proteinosis	Drug: GM-CSF [Leukine (Sargramostim)];Procedure: WLL	IRCCS Policlinico S. Matteo	Agenzia Italiana del Farmaco	Enrolling by invitation	18 Years	N/A	Both	18	Phase 2/Phase 3	Italy
3	EUCTR2008-007086-23-IT (EUCTR)	12/12/2008	27/01/2009	Whole lung lavage followed by inhaled Sargramostim in the treatment of autoimmune pulmonary alveolar ...	Whole lung lavage followed by inhaled Sargramostim in the treatment of autoimmune pulmonary alveolar ...	Autoimmune PAP MedDRA version: 9.1;Level: LLT;Classification code 10037316;Term: Pulmonary alveolar ...	Trade Name: Leukine INN or Proposed INN: Sargramostim	OSPEDALE POLICLINICO S. MATTEO	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy

First Previous1Next Last